SUBSCRIBE
SUBSCRIBE

Diagnostics

Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 19
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 19, 2021.
January 19, 2021
 · 
6 min read
 · 
BioSpace Editorial Staff
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 12
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 12, 2021.
January 12, 2021
 · 
4 min read
 · 
BioSpace Editorial Staff
Policy
New COVID-19 Mutation Could Mess Up Tests, Trigger False Negatives
On Friday, the U.S. Food and Drug Administration (FDA) issued an official alert stating that it could trigger false negatives in COVID-19 tests.
January 11, 2021
 · 
2 min read
 · 
Heather McKenzie
Genetown
Glympse Advances BioSensors for NASH and Other Protease-Mediated Diseases
Glympse Bio’s tunable biosensors are poised to be a game-changing diagnostic tool in 2021.
January 6, 2021
 · 
4 min read
 · 
Gail Dutton
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 5
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 5, 2021.
January 4, 2021
 · 
3 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: December 29
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 29, 2020.
December 22, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: December 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 22, 2020.
December 22, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
FDA
FDA Approves First Non-Prescription, OTC Test for At-Home COVID-19 Detection
The U.S. Food and Drug Administration has authorized the first non-prescription, over-the-counter, at-home antigen test that can be used to identify infection with SARS-CoV-2, the virus responsible for COVID-19, in people two years of age or older.
December 16, 2020
 · 
3 min read
 · 
Brandon May
Photo courtesy of Quanterix.
Drug Development
Non-Invasive Alternatives to PCR Testing Yield Accurate Results
Detecting the presence of SARS-CoV-2 in asymptomatic individuals has been a challenge not even PCR – the gold standard of testing – can adequately address. Now two companies have developed novel solutions with the sensitivity and specificity needed to provide ample warning.
December 16, 2020
 · 
4 min read
 · 
Gail Dutton
Drug Development
Biopharma Update on the Novel Coronavirus: December 15
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 15, 2020.
December 15, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Press Releases
CNS Lymphoma Market Size to Grow at a CAGR of 4.01% during 2025-2035, Impelled by Advancements in Early Detection
January 21, 2025
 · 
8 min read
Press Releases
Acute Intermittent Porphyria Market Size to Reach USD 2.57 Million by 2035, Impelled by Advancements in Early Detection
January 21, 2025
 · 
7 min read
Press Releases
IntelliGenome Receives FDA Breakthrough Device Designation for CRISPR-TB Blood Test
January 21, 2025
 · 
1 min read
Press Releases
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® PSA Screening Test to Detect an Early Sign of Prostate Cancer
January 17, 2025
 · 
5 min read
Press Releases
Biomerica Reports Second Quarter Fiscal 2025 Financial Results
January 16, 2025
 · 
6 min read
Press Releases
Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease Research
January 16, 2025
 · 
5 min read
Press Releases
RID Launches a One-Button Solution for Microbiology Testing That Provides Pathogen ID and Antibiotic Sensitivity in 5 Hours
January 16, 2025
 · 
2 min read
Press Releases
PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics
January 15, 2025
 · 
6 min read
Press Releases
Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy Loss
January 15, 2025
 · 
5 min read
Press Releases
Applied BioCode Announces New Nucleic Acid Extraction Claim for KingFisher™ Flex Nucleic Acid Purification System with BioCode® Gastrointestinal Pathogen Panel (GPP)
January 15, 2025
 · 
4 min read
Press Releases
Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson’s Disease
January 14, 2025
 · 
7 min read
Press Releases
Spear Bio Secures FDA Breakthrough Device Designation for its Novel pTau 217 Blood Test, Advancing Scalable Solutions for Early Alzheimer’s Disease Diagnosis
January 14, 2025
 · 
3 min read
Press Releases
Baylor Genetics to Integrate with Epic Aura to Enhance Efficiency and Deliver Genetic Testing Results to Hospitals and Health Systems
January 14, 2025
 · 
3 min read
Press Releases
Patient Reported Outcomes for GRAIL’s Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology
January 14, 2025
 · 
8 min read
Press Releases
Landmark Clinical Study Validates Patch-Based Onera Home-Polysomnography System in One of the Largest Sleep Diagnostic Trials of the Decade
January 13, 2025
 · 
4 min read
Press Releases
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance
January 13, 2025
 · 
7 min read
Press Releases
NCCN Guidelines Updated to Include ctDNA-MRD Testing Recommendation for B-Cell Lymphoma
January 13, 2025
 · 
4 min read
Press Releases
QIAGEN Increases QIAcuity Digital PCR High-Order Multiplexing Capabilities to Gain Deeper Insights From Biological Samples
January 10, 2025
 · 
7 min read
Press Releases
Accelerated Demand for Cytovale’s FDA-Cleared Sepsis Detection Solution, IntelliSep®, to Drive Growth in 2025
January 10, 2025
 · 
4 min read
Press Releases
Assessing Post-Cardiac Surgery Kidney Recovery Through PenKid’s Emerging Role in Renal Replacement Therapy Decisions
January 9, 2025
 · 
4 min read
Load More